Mesothelioma Treatment
Recommended Topics
Mesothelioma Trust Funds

Over 30 Billion dollars in trust fund money has been set aside for asbestos victims.

Mesothelioma Support Books

Get a Free copy of Surviving Mesothelioma, Lean on Me, or 100 Questions & Answers About Mesothelioma

Free Veterans Assistance

Mesolink.org now offeres Free Assistance with VA Claims and other benefits.

Dr. Raphael Bueno

Contact Information

Dr. Raphael Bueno is the Associate Chief of the Division of Thoracic Surgery for Brigham and Women’s Hospital, located in Boston, Massachusetts—a position he has held since 2002. Brigham and Women’s Hospital is a teaching affiliate of Harvard University’s College of Medicine. He has been with the Thoracic Surgery division for over 10 years.

Dr. Bueno, who is also an Associate Professor of Surgery at Harvard Medical School, received his Bachelor’s Degree from Harvard in 1981 and his M.D. in 1985. His hospital internship and surgical residency were both completed at Brigham and Women’s Hospital.

Dr. Bueno has a number of highlights to his career, including being named Director of the Photodynamic Therapy Program, and Manager of the Thoracic Immediate Care Unit. He has done extensive research that his been subsequently published in medical journals. The U.S. News and World Report has praised Dr. Bueno for his research.

As an expert in thoracic medicine, his clinical focus is on diseases like lung cancer, mesothelioma, esophageal cancer, and benign esophageal disorders. The Brigham and Women’s Hospital where Dr. Bueno practices has a program called the International Mesothelioma Program (IMP), which treats mesothelioma patients and conducts important research in the field. The objective of the research at the IMP is to understand all aspects of mesothelioma, from its cause and development to improved methods of treatment.

Besides assisting with the efforts of the IMP at Brigham and Women’s, Dr. Bueno also conducts his own research, which concentrates on the characterization of the behavior of malignant pleural mesothelioma and lung cancer at the molecular level. The goal is discover new diagnostic tools for each disease, as well as new ways to determine treatment for patients. In order to aid his research, Dr. Bueno has put together a team of pathologists, surgeons, radiologists and scientists to develop predictive and diagnostic tests for patients who have lung cancer and mesothelioma. This has resulted in one test that has been shown, through the use of clinical trials, to accurately determine which mesothelioma patients would be helped by surgery. Because of the test’s success in these clinical trials, it is being added to the diagnostic program for mesothelioma patients at Brigham and Women’s Hospital.

Dr. Bueno’s research, combined with the research of the International Mesothelioma Program and Brigham and Women’s Hospital, is intended to answert many of the questions associated with mesothelioma, including which environmental factors can make mesothelioma progress; whether or not there are specific genetic factors that may predispose some to develop mesothelioma because of contamination in the environment; whether there are biological markers that can help doctors diagnose mesothelioma, pinpoint an accurate prognosis, and determine the best therapies for it; and if there are any innovative techniques that can extend a mesothelioma patient’s life while improving quality of life.

Patients who have malignant mesothelioma may wish to look more closely at Dr. Bueno’s research of the disease and his expertise in treating mesothelioma and lung cancer. They may very well find that his work could be quite beneficial to them. He also has a number of funded clinical trials being conducted at Brigham and Women’s Hospital as part of his research into mesothelioma.